Study Of SU011248 In Combination With Paclitaxel/Carboplatin In Patients With Advanced Solid Tumors

NCT00511849 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: carboplatin + SU011248 (sunitinib) + paclitaxel

Sponsor

Pfizer